Clinical commentary on the broadening spectrum of myelin oligodendrocyte glycoprotein

Abstract

Get full access to this article

View all access options for this article.

References

Linington

Engelhardt

Kapocs

, et al. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 1992; 40(2–3): 219–224.

Wingerchuk

Banwell

Bennett

, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85: 177–189.

Deschamps

Poillon

Marill

, et al. Myelin oligodendrocyte glycoprotein antibody associated diffuse orbital inflammation. Mult Scler 2020; 26(11): 1441–1443.

Chen

Flanagan

Jitprapaikulsan

, et al. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: Clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol 2018; 195: 8–15.

Reindl

Waters

Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol 2019; 15(2): 89–102.

Cobo-Calvo

Ruiz

Maillart

, et al. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. Neurology 2018; 90: e1858–e1869.

Clinical commentary on the broadening spectrum of myelin oligodendrocyte glycoprotein–associated disorder (MOGAD)

Abstract

Get full access to this article

References